Ratings Great-West Lifeco Inc. Börse Stuttgart

Equities

GWS

CA39138C1068

Real-time Estimate Tradegate Other stock markets 10:52:13 26/06/2024 pm IST			5-day change	1st Jan Change
26.7 ^EUR	+1.14%		+0.76%	-10.81%

05/06	Great-West Lifeco Brief: Adds common shares do not trade on a recognized stock exchange in the United States	MT
05/06	Great-West Lifeco Brief: Says Unsolicited offer represents a discount of Near 34.42% to Closing price of the common shares on TSX on May 17, 2024, the last trading day before the offer was commenced	MT

Strengths

Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 73% by 2026.
The company's attractive earnings multiples are brought to light by a P/E ratio at 9.46 for the current year.
The company is one of the best yield companies with high dividend expectations.
Over the past twelve months, analysts' opinions have been strongly revised upwards.
Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Ratings chart - Surperformance

Sector: Life & Health Insurance

	1st Jan change	Capi.	ESG Refinitiv
GREAT-WEST LIFECO INC.	-10.81%	26.86B	-
AXA	+3.97%	72.47B	B-
AFLAC INCORPORATED	+7.95%	51.15B	B
METLIFE, INC.	+6.58%	50.78B	B+
MANULIFE FINANCIAL CORPORATION	+20.47%	47.4B	B+
PRUDENTIAL FINANCIAL, INC.	+13.10%	42.58B	B+
GENERALI	+22.22%	38.93B	B
CHINA PACIFIC INSURANCE (GROUP) CO., LTD.	+16.65%	33.75B	B
SUN LIFE FINANCIAL INC.	-3.67%	28.35B	B
CATHAY FINANCIAL HOLDING CO., LTD.	+30.05%	27.28B	A

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes